Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot study of ARA290 for neuropathic pain and retinal edema in diabetes mellitus
2010-021518-45Phase 2Active
- Sponsor
- Leiden University Medical Center
- Start
- Jun 2010
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 2, single-arm trial of cibinetide in Neuralgia, small fiber neuropathy (SFN), macular edema and 1 more, sponsored by Leiden University Medical Center. Primary endpoint: Pain relief on VAS over 4 weeks. Started Jun 2010; status: active.
02
Drugs
cibinetide
03
Conditions
Neuralgiasmall fiber neuropathy (SFN)macular edematype 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2010-021518-45.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-021518-45.